Sfoglia per Rivista HAEMATOLOGICA
P022 | Fourier-transform infrared spectroscopy analysis of plasma-derived extracellular vesicles as a tool to detect TKI-related toxicity in chronic myeloid leukemia patients: a preliminary study
2026-01-01 Mutti, S.; Cavalleri, A.; Sicuranza, A.; Leoni, A.; Trenta, F.; Garuffo, L.; Xhahysa, B.; Re, F.; Bocchia, M.; Farina, M.; Malagola, M.; Russo, D.; Bernardi, S.
P026 | Tracking residual chronic myeloid leukemia: complementary insights from CD26⁺ stem cells and extracellular BCR::ABL1
2026-01-01 Cavalleri, A.; Mutti, S.; Sicuranza, A.; Pacelli, P.; Leoni, A.; Ielo, C.; Paolini, L.; Mangolini, V.; Miracapillo, T.; Turriziani, C.; Abruzzese, E.; Farina, M.; Radeghieri, A.; Malagola, M.; Breccia, M.; Bocchia, M.; Russo, D.; Bernardi, S.
P044 | From cells to vesicles: next-generation measurable residual disease tracking in acute myeloid leukemia with NGS and digital PCR
2026-01-01 Leoni, A.; Farina, M.; Borlenghi, E.; Garuffo, L.; Xhahysa, B.; Cavalleri, A.; Trenta, F.; Re, F.; Mutti, S.; Morello, E.; Avenoso, D.; Russo, D.; Malagola, M.; Bernardi, S.
P046 | Beyond the mutation: prognostic role of FLT3-ITD length and genomic context in acute myeloid leukemia
2026-01-01 Leoni, A.; Farina, M.; Bertoli, D.; Giupponi, C.; Borlenghi, E.; Xhahysa, B.; Garuffo, L.; Cavalleri, A.; Trenta, F.; Re, F.; Mutti, S.; Avenoso, D.; Russo, D.; Malagola, M.; Bresciani, R.; Biasiotto, G.; Bernardi, S.
P170-dependent multidrug resistance. Restoring full sensitivity to idarubicin with verapamil and cyclosporin a derivatives
1994-01-01 Michieli, M; Damiani, D; Michelutti, A; Melli, C; Russo, Domenico; Fanin, R; Baccarani, M.
PARAMETERS OF PROTEIN METABOLISM AND THYROID FUNCTION AS PREDICTORS OF A SCORING SYSTEM FOR ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE
2015-01-01 Skert, C.; Turra, A.; Malagola, Michele; Perucca, Simone; Cancelli, V.; Daffini, R.; Ribolla, R.; Bergonzi, C.; Filì, C.; Pagani, C.; DI PALMA, Andrea; Cattina, F.; Russo, Domenico
Pharmacology treatment of chronic asthma.
1998-01-01 Grassi, Vittorio; M., Malerba; S., Cossi; Tantucci, Claudio
Phase II multicentric explorative study of Intermittent Imatinib (IM) treatment (INTERIM) in elderly patients with Ph+ chronic myeloid leukemia (CML) who achieved a stable complete cytogenetic response (CCgR) with standard IM therapy.
2009-01-01 Russo, Domenico; Rosti, G; Martinelli, G; Malagola, Michele; Mirto, S; Turri, D; Gobbi, M; Pierri, I; Vitolo, U; Pregno, P; Di Raimondo, F; Stagno, F; Foà, R; Alimena, G; Breccia, M; Rambaldi, A; Intermesoli, T; Saglio, G; Rege Cambrin, G; Visani, G; Nicolini, G; De Fabritiis, P; Abruzzese, E; Nobile, F; Martino, B; Fanin, R; Tiribelli, M; Galieni, P; Bigazzi, C; Liso, V; Specchia, G; Angelucci, E; Usala, E; Musolino, C; Russo, S; Gaidano, G; Lunghi, M; Lauria, F; Bocchia, M; Quarta, G; Girasoli, M; Bosi, A; Santini, V; Fioritoni, G; Di Lorenzo, R; Colombi, C; Fogli, M; Amabile, M; De Vivo, A; B. a. c. c. a. r. a. n. i., M.
Phase II multicentric explorative study of Intermittent Imatinib (IM) treatment (INTERIM) in elderly patients with Ph+ chronic myeloid leukemia (CML) who achieved a stable complete cytogenetic response (CCgR) with standard IM therapy.
2009-01-01 Russo, Domenico; Rosti, G; Martinelli, G; Malagola, Michele; Mirto, S; Turri, D; Vitolo, U; Pregno, P; Gobbi, M; Pierri, I; Di Raimondo, F; Stagno, F; Foà, R; Alimena, G; Breccia, M; Saglio, G; Rege Cambrin, G; De Fabritiis, P; Abruzzese, E; Fanin, R; Tiribelli, M; Galieni, P; Bigazzi, C; Liso, V; Specchia, G; Rambaldi, A; Intermesoli, T; Lauria, F; Bocchia, M; Quarta, G; Girasoli, M; Angelucci, E; Usala, E; Bosi, A; Santini, V; Colombi, C; Fogli, M; Amabile, M; De Vivo, A; B. a. c. c. a. r. a. n. i., M.
Phase II pilot trial of gemtuzumab ozogamicin (mylotarg) in combination with fludarabine, cytarabine, idarubicin (FLAI) as induction therapy in CD33+ AML patients younger than 65 years.
2008-01-01 Candoni, A; Martinelli, G; Tiribelli, M; Simeone, E; Toffoletti, E; Michelutti, A; Chiarvesio, A; Malagola, Michele; Piccaluga, Pp; Russo, Domenico; Fanin, R.
Phase II study of bisantrene in relapsed/refractory acute non lymphoid leukemias (ANLL)
1989-01-01 Tosi, P.; Visani, G.; Colombini, R.; Verlicchi, F.; Benfenati, D.; Cenacchi, A.; Russo, Domenico; Zuffa, E.; Papadopulu, P.; Tura, S.
Pilot study of combined therapy with interferon-alfa, arabinosyl cytosine and all-trans retinoic acid in patients with chronic myeloid leukemia in the chronic phase
1999-01-01 Russo, Domenico; Marin, L.; Bertone, A.; Tiribelli, M.; Testoni, N.; Martinelli, Giovanna
Plasma cell P170 expression and response to treatment in multiple myeloma
1996-01-01 Patriarca, F.; Melli, C.; Damiani, D.; Michieli, M.; Fanin, R.; Russo, Domenico; Michelutti, A.; Cavo, M.; Baccarani, M.
Polarization dictates iron handling by inflammatory and alternatively activated macrophages.
2010-01-01 G., Corna; L., Campana; E., Pignatti; A., Castiglioni; E., Tagliafico; L., Bosurgi; A., Campanella; S., Brunelli; A. A., Manfredi; Apostoli, Pietro; L., Silvestri; C., Camaschella; P., Rovere Querini
Polyclonal T-cell expansions in a HIV(+) patient with atypical cutaneous lymphoproliferative disorder, large granular lymphocyte proliferation and SENV infection
2001-01-01 Pirovano, S; Signorini, L; Facchetti, F; Santoro, A; Albertin, A; Imberti, L
POSSIBLE CORRELATION BETWEEN DIFFERENT TOLL-LIKE RECEPTORS, MONOCYTES, LYMPHOCYTE SUBSETS, TYPE OF INFECTIONS AND OUTCOME AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
2013-01-01 Skert, C; Fogli, M; Perucca, S; Garrafa, E; Fiorentini, S; Fili, C; Bergonzi, C; Malagola, M; Ribolla, R; Turra, A; Cattina, F; Alghisi, E; Cancelli, V; Caruso, A; Russo, D
POST REMISSION MONITORING OF MINIMAL RESIDUAL DISEASE BY WT1 AND LEUKEMIA ASSOCIATED IMMUNOPHENOTYPE PREDICTS RELAPSE IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS
2015-01-01 Malagola, Michele; Skert, C.; Borlenghi, E.; Morello, E.; Chiarini, M.; Giustini, V.; Comini, F.; Turra, A.; Cattina, F.; Cancelli, V.; Cerqui, E.; Pagani, C.; Passi, A.; Ribolla, R.; Schieppati, F.; Brenardi, S.; Perucca, Simone; DI PALMA, Andrea; Ruggeri, G.; Rossi, G.; Caimi, Luigi; Russo, Domenico
POST REMISSION SEQUENTIAL MONITORING OF MINIMAL RESIDUAL DISEASE BY WT1 Q-PCR AND MULTIPARAMETRIC FLOW CYTOMETRY PREDICTS RELAPSE AND MAY HELP TO ADDRESS THE RISK ADAPTED THERAPY IN ACUTE MYELOID LEUKEMIA PATIENTS
2015-01-01 Malagola, Michele; Skert, C.; Borlenghi, E.; Chiarini, M.; Giustini, V.; Comini, F.; Cattina, F.; Cancelli, V.; Cerqui, E.; Farina, M.; Pagani, C.; Passi, A.; Schieppati, F.; Ribolla, R.; Ruggeri, G.; Caimi, Luigi; Russo, Domenico; Rossi, G.
Post-transplant evaluation of bone marrow hematopoietic function in patients receiving high-dose Yttrium-90-Ibritumomab Tiuxetan (Zevalin) with autograft
2009-01-01 Guidetti, A.; Carlo Stella, C.; Ruella, M.; Devizzi, L.; Sia, D.; Giacomini, A; Locatelli, S. L.; Testi, A.; Magni, M.; Di Nicola, M.; Matteucci, P.; Buttiglieri, S.; Risso, A.; Tarella, C.; Gianni, A. M.
PRE-FINAL ANALYSIS OF THE PHASE II EXPLORATIVE STUDY OF INTERMITTENT IMATINIB (IM) TREATMENT (INTERIM) IN ELDERLY PH+ CML PATIENTS WITH STABLE COMPLETE CYTOGENETIC RESPONSE (CCGR) – EUDRACT NUMBER 2007-005102-42, CLINICALTRIALS.GOV NCT 00858806.
2010-01-01 Russo, Domenico; Martinelli, G; Malagola, Michele; Colombi, C; Rosti, G; Amabile, M; Fogli, M; Mirto, S; Turri, D; Gobbi, M; Pierri, I; Vitolo, U; Pregno, P; Morra, E; Pungolino, E; Di Raimondo, F; Stagno, F; Foà, R; Alimena, G; Breccia, M; Nobile, F; Martino, B; Rambaldi, R; Intermesoli, T; Saglio, G; Rege Cambrin, G; Visani, G; Nicolini, G; De Fabritiis, P; Abruzzese, E; Fanin, R; Tiribelli, M; Galieni, P; Bigazzi, C; Liso, V; Specchia, G; Angelucci, E; Usala, E; Musolino, C; Russo, S; Gaidano, G; Lunghi, M; Lauria, F; Bocchia, M; Rodeghiero, F; D’Emilio, A; Bosi, A; Santini, V; Quarta, G; Girasoli, M; Fioritoni, G; Di Lorenzo, R.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| P022 | Fourier-transform infrared spectroscopy analysis of plasma-derived extracellular vesicles as a tool to detect TKI-related toxicity in chronic myeloid leukemia patients: a preliminary study | 1-gen-2026 | Mutti, S.; Cavalleri, A.; Sicuranza, A.; Leoni, A.; Trenta, F.; Garuffo, L.; Xhahysa, B.; Re, F.; Bocchia, M.; Farina, M.; Malagola, M.; Russo, D.; Bernardi, S. | |
| P026 | Tracking residual chronic myeloid leukemia: complementary insights from CD26⁺ stem cells and extracellular BCR::ABL1 | 1-gen-2026 | Cavalleri, A.; Mutti, S.; Sicuranza, A.; Pacelli, P.; Leoni, A.; Ielo, C.; Paolini, L.; Mangolini, V.; Miracapillo, T.; Turriziani, C.; Abruzzese, E.; Farina, M.; Radeghieri, A.; Malagola, M.; Breccia, M.; Bocchia, M.; Russo, D.; Bernardi, S. | |
| P044 | From cells to vesicles: next-generation measurable residual disease tracking in acute myeloid leukemia with NGS and digital PCR | 1-gen-2026 | Leoni, A.; Farina, M.; Borlenghi, E.; Garuffo, L.; Xhahysa, B.; Cavalleri, A.; Trenta, F.; Re, F.; Mutti, S.; Morello, E.; Avenoso, D.; Russo, D.; Malagola, M.; Bernardi, S. | |
| P046 | Beyond the mutation: prognostic role of FLT3-ITD length and genomic context in acute myeloid leukemia | 1-gen-2026 | Leoni, A.; Farina, M.; Bertoli, D.; Giupponi, C.; Borlenghi, E.; Xhahysa, B.; Garuffo, L.; Cavalleri, A.; Trenta, F.; Re, F.; Mutti, S.; Avenoso, D.; Russo, D.; Malagola, M.; Bresciani, R.; Biasiotto, G.; Bernardi, S. | |
| P170-dependent multidrug resistance. Restoring full sensitivity to idarubicin with verapamil and cyclosporin a derivatives | 1-gen-1994 | Michieli, M; Damiani, D; Michelutti, A; Melli, C; Russo, Domenico; Fanin, R; Baccarani, M. | |
| PARAMETERS OF PROTEIN METABOLISM AND THYROID FUNCTION AS PREDICTORS OF A SCORING SYSTEM FOR ACUTE AND CHRONIC GRAFT-VERSUS-HOST DISEASE | 1-gen-2015 | Skert, C.; Turra, A.; Malagola, Michele; Perucca, Simone; Cancelli, V.; Daffini, R.; Ribolla, R.; Bergonzi, C.; Filì, C.; Pagani, C.; DI PALMA, Andrea; Cattina, F.; Russo, Domenico | |
| Pharmacology treatment of chronic asthma. | 1-gen-1998 | Grassi, Vittorio; M., Malerba; S., Cossi; Tantucci, Claudio | |
| Phase II multicentric explorative study of Intermittent Imatinib (IM) treatment (INTERIM) in elderly patients with Ph+ chronic myeloid leukemia (CML) who achieved a stable complete cytogenetic response (CCgR) with standard IM therapy. | 1-gen-2009 | Russo, Domenico; Rosti, G; Martinelli, G; Malagola, Michele; Mirto, S; Turri, D; Gobbi, M; Pierri, I; Vitolo, U; Pregno, P; Di Raimondo, F; Stagno, F; Foà, R; Alimena, G; Breccia, M; Rambaldi, A; Intermesoli, T; Saglio, G; Rege Cambrin, G; Visani, G; Nicolini, G; De Fabritiis, P; Abruzzese, E; Nobile, F; Martino, B; Fanin, R; Tiribelli, M; Galieni, P; Bigazzi, C; Liso, V; Specchia, G; Angelucci, E; Usala, E; Musolino, C; Russo, S; Gaidano, G; Lunghi, M; Lauria, F; Bocchia, M; Quarta, G; Girasoli, M; Bosi, A; Santini, V; Fioritoni, G; Di Lorenzo, R; Colombi, C; Fogli, M; Amabile, M; De Vivo, A; B. a. c. c. a. r. a. n. i., M. | |
| Phase II multicentric explorative study of Intermittent Imatinib (IM) treatment (INTERIM) in elderly patients with Ph+ chronic myeloid leukemia (CML) who achieved a stable complete cytogenetic response (CCgR) with standard IM therapy. | 1-gen-2009 | Russo, Domenico; Rosti, G; Martinelli, G; Malagola, Michele; Mirto, S; Turri, D; Vitolo, U; Pregno, P; Gobbi, M; Pierri, I; Di Raimondo, F; Stagno, F; Foà, R; Alimena, G; Breccia, M; Saglio, G; Rege Cambrin, G; De Fabritiis, P; Abruzzese, E; Fanin, R; Tiribelli, M; Galieni, P; Bigazzi, C; Liso, V; Specchia, G; Rambaldi, A; Intermesoli, T; Lauria, F; Bocchia, M; Quarta, G; Girasoli, M; Angelucci, E; Usala, E; Bosi, A; Santini, V; Colombi, C; Fogli, M; Amabile, M; De Vivo, A; B. a. c. c. a. r. a. n. i., M. | |
| Phase II pilot trial of gemtuzumab ozogamicin (mylotarg) in combination with fludarabine, cytarabine, idarubicin (FLAI) as induction therapy in CD33+ AML patients younger than 65 years. | 1-gen-2008 | Candoni, A; Martinelli, G; Tiribelli, M; Simeone, E; Toffoletti, E; Michelutti, A; Chiarvesio, A; Malagola, Michele; Piccaluga, Pp; Russo, Domenico; Fanin, R. | |
| Phase II study of bisantrene in relapsed/refractory acute non lymphoid leukemias (ANLL) | 1-gen-1989 | Tosi, P.; Visani, G.; Colombini, R.; Verlicchi, F.; Benfenati, D.; Cenacchi, A.; Russo, Domenico; Zuffa, E.; Papadopulu, P.; Tura, S. | |
| Pilot study of combined therapy with interferon-alfa, arabinosyl cytosine and all-trans retinoic acid in patients with chronic myeloid leukemia in the chronic phase | 1-gen-1999 | Russo, Domenico; Marin, L.; Bertone, A.; Tiribelli, M.; Testoni, N.; Martinelli, Giovanna | |
| Plasma cell P170 expression and response to treatment in multiple myeloma | 1-gen-1996 | Patriarca, F.; Melli, C.; Damiani, D.; Michieli, M.; Fanin, R.; Russo, Domenico; Michelutti, A.; Cavo, M.; Baccarani, M. | |
| Polarization dictates iron handling by inflammatory and alternatively activated macrophages. | 1-gen-2010 | G., Corna; L., Campana; E., Pignatti; A., Castiglioni; E., Tagliafico; L., Bosurgi; A., Campanella; S., Brunelli; A. A., Manfredi; Apostoli, Pietro; L., Silvestri; C., Camaschella; P., Rovere Querini | |
| Polyclonal T-cell expansions in a HIV(+) patient with atypical cutaneous lymphoproliferative disorder, large granular lymphocyte proliferation and SENV infection | 1-gen-2001 | Pirovano, S; Signorini, L; Facchetti, F; Santoro, A; Albertin, A; Imberti, L | |
| POSSIBLE CORRELATION BETWEEN DIFFERENT TOLL-LIKE RECEPTORS, MONOCYTES, LYMPHOCYTE SUBSETS, TYPE OF INFECTIONS AND OUTCOME AFTER ALLOGENEIC STEM CELL TRANSPLANTATION | 1-gen-2013 | Skert, C; Fogli, M; Perucca, S; Garrafa, E; Fiorentini, S; Fili, C; Bergonzi, C; Malagola, M; Ribolla, R; Turra, A; Cattina, F; Alghisi, E; Cancelli, V; Caruso, A; Russo, D | |
| POST REMISSION MONITORING OF MINIMAL RESIDUAL DISEASE BY WT1 AND LEUKEMIA ASSOCIATED IMMUNOPHENOTYPE PREDICTS RELAPSE IN ACUTE MYELOID LEUKEMIA (AML) PATIENTS | 1-gen-2015 | Malagola, Michele; Skert, C.; Borlenghi, E.; Morello, E.; Chiarini, M.; Giustini, V.; Comini, F.; Turra, A.; Cattina, F.; Cancelli, V.; Cerqui, E.; Pagani, C.; Passi, A.; Ribolla, R.; Schieppati, F.; Brenardi, S.; Perucca, Simone; DI PALMA, Andrea; Ruggeri, G.; Rossi, G.; Caimi, Luigi; Russo, Domenico | |
| POST REMISSION SEQUENTIAL MONITORING OF MINIMAL RESIDUAL DISEASE BY WT1 Q-PCR AND MULTIPARAMETRIC FLOW CYTOMETRY PREDICTS RELAPSE AND MAY HELP TO ADDRESS THE RISK ADAPTED THERAPY IN ACUTE MYELOID LEUKEMIA PATIENTS | 1-gen-2015 | Malagola, Michele; Skert, C.; Borlenghi, E.; Chiarini, M.; Giustini, V.; Comini, F.; Cattina, F.; Cancelli, V.; Cerqui, E.; Farina, M.; Pagani, C.; Passi, A.; Schieppati, F.; Ribolla, R.; Ruggeri, G.; Caimi, Luigi; Russo, Domenico; Rossi, G. | |
| Post-transplant evaluation of bone marrow hematopoietic function in patients receiving high-dose Yttrium-90-Ibritumomab Tiuxetan (Zevalin) with autograft | 1-gen-2009 | Guidetti, A.; Carlo Stella, C.; Ruella, M.; Devizzi, L.; Sia, D.; Giacomini, A; Locatelli, S. L.; Testi, A.; Magni, M.; Di Nicola, M.; Matteucci, P.; Buttiglieri, S.; Risso, A.; Tarella, C.; Gianni, A. M. | |
| PRE-FINAL ANALYSIS OF THE PHASE II EXPLORATIVE STUDY OF INTERMITTENT IMATINIB (IM) TREATMENT (INTERIM) IN ELDERLY PH+ CML PATIENTS WITH STABLE COMPLETE CYTOGENETIC RESPONSE (CCGR) – EUDRACT NUMBER 2007-005102-42, CLINICALTRIALS.GOV NCT 00858806. | 1-gen-2010 | Russo, Domenico; Martinelli, G; Malagola, Michele; Colombi, C; Rosti, G; Amabile, M; Fogli, M; Mirto, S; Turri, D; Gobbi, M; Pierri, I; Vitolo, U; Pregno, P; Morra, E; Pungolino, E; Di Raimondo, F; Stagno, F; Foà, R; Alimena, G; Breccia, M; Nobile, F; Martino, B; Rambaldi, R; Intermesoli, T; Saglio, G; Rege Cambrin, G; Visani, G; Nicolini, G; De Fabritiis, P; Abruzzese, E; Fanin, R; Tiribelli, M; Galieni, P; Bigazzi, C; Liso, V; Specchia, G; Angelucci, E; Usala, E; Musolino, C; Russo, S; Gaidano, G; Lunghi, M; Lauria, F; Bocchia, M; Rodeghiero, F; D’Emilio, A; Bosi, A; Santini, V; Quarta, G; Girasoli, M; Fioritoni, G; Di Lorenzo, R. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile